Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaopu Hu

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|April 29, 2026
LncRNA DLEU1 as a novel therapeutic target and prognostic biomarker in various malignancies: a meta-analysis, bioinformatics analysis and systematic reviewShaopu Hu, Yanru Cai, Qian Yang
Frontiers in Oncology|April 18, 2022
Integrated Network Pharmacology and Experimental Verification to Explore the Molecular Mechanism of Hedysarum Multijugum Maxim-Curcumae Rhizoma Herb Pair for Treating Non-Small Cell Lung CancerShaopu Hu, Mengxue Ge, Shuixiu Zhang, et al.
Journal of Ethnopharmacology|January 1, 2023
Integrated network pharmacology and experimental verification to explore the molecular mechanism of Jingxin Zhidong formula for treating Tic disorderXue Tian, Guangyin Ou, Shaopu Hu, et al.
Cancer Management and Research|May 23, 2019
Efficacy and safety of olaparib maintenance therapy in platinum-sensitive ovarian cancer patients with <i>BRCA</i> mutations: a meta-analysis on randomized controlled trialsJiao Ma, Hongyong Deng, Jiajia Li, et al.
Scientific Reports|August 10, 2017
Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivoJunli Chang, Yimian Li, Xianyang Wang, et al.
Journal of Bone and Mineral Metabolism|November 18, 2022
The crosstalk between LINC01089 and hippo pathway inhibits osteosarcoma progressionHao Zhang, Lin Zhou, Shaopu Hu, et al.
Oncotarget|March 24, 2018
Long non-coding RNA XIST as a potential prognostic biomarker in human cancers: a meta-analysisShaopu Hu, Junli Chang, Yimian Li, et al.
Journal of Ethnopharmacology|April 4, 2025
Combining network pharmacology and transcriptomics to validate and explore the efficacy and mechanism of Huayu Wan in treating non-small cell lung cancerTangke Gao, Shaopu Hu, Min Jiang, et al.
Journal of Cancer|December 7, 2018
Down-Regulated microRNA-34a Expression as a Prognostic Marker for Poor Osteosarcoma in Mice: A Systematic Review and Meta-AnalysisWenyi Wang, Shaopu Hu, Junli Chang, et al.
Molecular Medicine Reports|May 31, 2018
Matrine inhibits prostate cancer via activation of the unfolded protein response/endoplasmic reticulum stress signaling and reversal of epithelial to mesenchymal transitionJunli Chang, Shaopu Hu, Wenyi Wang, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|April 29, 2026
LncRNA DLEU1 as a novel therapeutic target and prognostic biomarker in various malignancies: a meta-analysis, bioinformatics analysis and systematic reviewShaopu Hu, Yanru Cai, Qian Yang
Frontiers in Oncology|April 18, 2022
Integrated Network Pharmacology and Experimental Verification to Explore the Molecular Mechanism of Hedysarum Multijugum Maxim-Curcumae Rhizoma Herb Pair for Treating Non-Small Cell Lung CancerShaopu Hu, Mengxue Ge, Shuixiu Zhang, et al.
Journal of Ethnopharmacology|January 1, 2023
Integrated network pharmacology and experimental verification to explore the molecular mechanism of Jingxin Zhidong formula for treating Tic disorderXue Tian, Guangyin Ou, Shaopu Hu, et al.
Cancer Management and Research|May 23, 2019
Efficacy and safety of olaparib maintenance therapy in platinum-sensitive ovarian cancer patients with <i>BRCA</i> mutations: a meta-analysis on randomized controlled trialsJiao Ma, Hongyong Deng, Jiajia Li, et al.
Scientific Reports|August 10, 2017
Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivoJunli Chang, Yimian Li, Xianyang Wang, et al.
Journal of Bone and Mineral Metabolism|November 18, 2022
The crosstalk between LINC01089 and hippo pathway inhibits osteosarcoma progressionHao Zhang, Lin Zhou, Shaopu Hu, et al.
Oncotarget|March 24, 2018
Long non-coding RNA XIST as a potential prognostic biomarker in human cancers: a meta-analysisShaopu Hu, Junli Chang, Yimian Li, et al.
Journal of Ethnopharmacology|April 4, 2025
Combining network pharmacology and transcriptomics to validate and explore the efficacy and mechanism of Huayu Wan in treating non-small cell lung cancerTangke Gao, Shaopu Hu, Min Jiang, et al.
Journal of Cancer|December 7, 2018
Down-Regulated microRNA-34a Expression as a Prognostic Marker for Poor Osteosarcoma in Mice: A Systematic Review and Meta-AnalysisWenyi Wang, Shaopu Hu, Junli Chang, et al.
Molecular Medicine Reports|May 31, 2018
Matrine inhibits prostate cancer via activation of the unfolded protein response/endoplasmic reticulum stress signaling and reversal of epithelial to mesenchymal transitionJunli Chang, Shaopu Hu, Wenyi Wang, et al.
Pageof 2